McKesson (MCK) stock: Winston Score and insider trades

§Winston Score History

McKesson Corporation is one of the largest healthcare distribution companies in the United States. It moves medicines, medical supplies, and healthcare products from manufacturers to hospitals, pharmacies, and doctors' offices. Think of McKesson as a giant middleman that makes sure the right drugs and supplies get to the right places across the country.

McKesson makes money by buying products in bulk from drug makers and selling them to healthcare providers, earning a small margin on each transaction — which explains the very thin gross margins. It operates primarily in the United States, with some international presence, and generates over $300 billion in annual revenue, making it one of the largest companies in America by sales. Its size and deep relationships with suppliers and customers create a strong competitive position that is hard for smaller rivals to match. The main risk is that pricing pressure from large pharmacy chains and potential changes to drug distribution regulations could squeeze its already narrow margins further.

Politician Trades

22 trades / 12mo

15 Congressional buys and 7 sells on MCK in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.7% YoY

YoY Growth Rate

Slow revenue growth

Reported EPS Growth

-17.7% YoY

Quarterly reporting periods ended:

30 Jun 2025: $6.28

30 Jun 2026: $5.17

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS decreased year over year

R&D Spend

$103M/ year

↑ Rising (+13% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

0.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~4 years

$5.2B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

$5.2B cash & investments at current burn rate

Growth context

McKesson Corporation is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

3.5%

Thin — 3.5% gross margin

Profit after running costs

Operating Margin

1.3%

Thin — 1.3% operating margin

Return on the money invested

ROCE

17.7%

Strong — 17.7% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+8.8%

Steady sales growth (+8.8% YoY)

Profit growth

EPS YoY

+49.0%

Earnings growing fast (+49.0% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

149%

Turns 149% of profit into real cash

Spare cash per sale

FCF Margin

1.5%

Thin free cash flow (1.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

—

Data not available

Covers its interest

Interest Cover

43.49x

Comfortably covers interest (43.5x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

26.7x

Growth-priced — P/E 26.7

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year

P/E vs Forward

+11.4

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (26.7 → 15.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

0.44%

Small dividend — 0.44% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

+15.3%

Dividend growing fast (15.3% YoY)

Payout Ratio

9%

no trend

Pays out a modest share of profit and keeps the rest to reinvest. Room to keep paying through a weak year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial

McKesson Corporation

§How the score breaks down

Share count falling — buybacks

§Winston Score History

Politician Trades

Growth Profile

Every number that matters to educated investors.

Quality

Growth

Cash Flow

Stability

Valuation

Dividends